← back to search

Xiaohong Pu

Nanjing Drum Tower Hospital · CN
Area of research
Surgery · Oncology
Research interest
Research interests include Cholangiocarcinoma and Gallbladder Cancer Studies, Pancreatic and Hepatic Oncology Research, Lung Cancer Treatments and Mutations, and HER2/EGFR in Cancer Research.
h-index
12
citations
765
works
54
NIH funding
primary concept
Medicine
email

Recent publications

Clinical and pathological heterogeneity of four common fusion subtypes in Xp11.2 translocation renal cell carcinoma
Frontiers in Oncology 2023cited by 10position: middledoi
Cancer cells escape autophagy inhibition via NRF2-induced macropinocytosis
Cancer Cell 2021cited by 217position: middledoi
ALK rearrangement in TFE3-positive renal cell carcinoma: Alternative diagnostic option to exclude Xp11.2 translocation carcinoma
Pathology - Research and Practice 2020cited by 8position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Hongqian Guo · Nanjing Drum Tower Hospital2 papers (2020–2023)Wei Guo · University of Wyoming2 papers (2020–2023)Yiqi Zhu · Guangzhou University of Chinese Medicine2 papers (2020–2023)María T. Díaz‐Meco · Cornell University1 papers (2021–2021)Beicheng Sun · Peking Union Medical College Hospital1 papers (2021–2021)Rao Fu · Ministry of Agriculture and Rural Affairs1 papers (2021–2021)Evangeline Mose · San Diego Cardiac Center1 papers (2021–2021)Avi Kumar · Salk Institute for Biological Studies1 papers (2021–2021)Jorge Moscat · Cornell University1 papers (2021–2021)Yinling Hu · National Institutes of Health1 papers (2021–2021)Junlai Liu · China University of Geosciences (Beijing)1 papers (2021–2021)Christian M. Metallo · Salk Institute for Biological Studies1 papers (2021–2021)Fei Yang · Affiliated Hospital of North Sichuan Medical College1 papers (2021–2021)Brittney Trinh · University of Minnesota1 papers (2021–2021)Michael Karin · Discovery Institute1 papers (2021–2021)Hua Su · Central South University1 papers (2021–2021)Weidong Gan · Nanjing University of Chinese Medicine1 papers (2020–2020)Jelena Todoric · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2021–2021)Andrew M. Lowy · San Diego Cardiac Center1 papers (2021–2021)Yuan Liu · Jiangsu T-mab BioPharma (China)1 papers (2021–2021)